California considers seal of approval for foods that are not ultra-processed

• by Sarah Todd

• March 25, 2026

GLP-1 Analysis: Riding the Wave of Peptide Innovation

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

• by Amanda M. Guiraldelli, Piotr Alvarez, Koen Sandra

• April 9, 2026

• 18 min

Variations in Cardiovascular Disease Risk Factor Prevalence Among London Adults: Insights from the TOGETHER Study

• by Fotios Barkas, Malo Dirou, Kanika I. Dharmayat, Mahsa Mazidi, Antonio J. Vallejo-Vaz, Christophe A. T. Stevens, Amany Elshorbagy, Kausik K. Ray

• March 3, 2026

Exercise habits and the risk of cardiovascular disease among adults with overweight or obesity: a longitudinal cohort analysis

• by Kai Mu, Yanan Qiao, Ruilang Lin, Yongfu Yu, Min Zhao, Costan G. Magnussen, Bo Xi

• February 16, 2026